Serial 98373742
Live / Applied — Second extension granted (statement of use) (as of 27 Nov 2025)
What this means for you
Not registered yet, but its 24 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98373742
- Mark type
- Design / logo
- Filed
- 24 Jan 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders;
Owner
- Orgenesis Inc., GERMANTOWN, MD, US
- Orgenesis Inc., GERMANTOWN, MD, US
Prosecution history
- 28 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2025 — SOU EXTENSION 2 GRANTED
- 27 Nov 2025 — SOU EXTENSION 2 FILED
- 27 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 1 GRANTED
- 02 Jun 2025 — SOU EXTENSION 1 FILED
- 05 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Sept 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 08 Sept 2025 — NOTICE OF REVIVAL - E-MAILED
- 08 Sept 2025 — PETITION TO REVIVE-GRANTED
- 08 Sept 2025 — TEAS PETITION TO REVIVE RECEIVED
- 07 Jul 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Jul 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT